Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
Author
Boykin, Christi; Zhang, G.; Chen, Yan-Hua; Zhang, R-W; Fan, X-E; Yang, W-M; Lu, Q.
Date
2011-03
Citation:
APA:
Boykin, Christi, & Zhang, G., & Chen, Yan-Hua, & Zhang, R-W, & Fan, X-E, & Yang, W-M, & Lu, Q.. (March 2011).
Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation.
British Journal of Cancer,
104(5),
781-
789. Retrieved from
http://hdl.handle.net/10342/5298
MLA:
Boykin, Christi, and Zhang, G., and Chen, Yan-Hua, and Zhang, R-W, and Fan, X-E, and Yang, W-M, and Lu, Q..
"Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation". British Journal of Cancer.
104:5. (781-789),
March 2011.
September 27, 2023.
http://hdl.handle.net/10342/5298.
Chicago:
Boykin, Christi and Zhang, G. and Chen, Yan-Hua and Zhang, R-W and Fan, X-E and Yang, W-M and Lu, Q.,
"Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation," British Journal of Cancer 104, no.
5 (March 2011),
http://hdl.handle.net/10342/5298 (accessed
September 27, 2023).
AMA:
Boykin, Christi, Zhang, G., Chen, Yan-Hua, Zhang, R-W, Fan, X-E, Yang, W-M, Lu, Q..
Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation. British Journal of Cancer.
March 2011;
104(5):
781-789.
http://hdl.handle.net/10342/5298. Accessed
September 27, 2023.
Collections